47045-PAK-T-MC-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Tuberculosis - Pakistan (01-Oct-2012-30-Jun-2015)</narrative> Pakistan, Tuberculosis, Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division xxxx xxxx Fund Portfolio Manager +41 58 791 1700 xxxx https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Pakistan Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases 1633192.00 Global Fund disbursement to PAK-T-MCP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 3196659.00 Global Fund disbursement to PAK-T-MCP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2273996.00 Global Fund disbursement to PAK-T-MCP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 8064554.00 Global Fund commitment to PAK-T-MCP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2978263.00 Global Fund commitment to PAK-T-MCP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -960707.00 Global Fund commitment to PAK-T-MCP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2203207.00 Global Fund disbursement to PAK-T-MCP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -775056.00 Global Fund commitment to PAK-T-MCP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. 47045-PAK-T-MC-2 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>NULL - Pakistan (01-Jul-2015-31-Dec-2017)</narrative> Pakistan, Tuberculosis, Mercy Corps Goals: Contribute to achieving the goal of the national strategy to control TB in Pakistan which is to reduce by 50% the prevalence of TB by 2025 in comparison to 2011; Contribute towards decreasing the prevalence, by at least 5% per year from 2018 onwards, the prevalence of MDR-TB among TB patients who have never received any TB treatment. Objectives: To enhance MDR-TB enrolment from 18% of estimated cases in 2013-14 to 23% of estimated by 2017; To increase TB case notification (all forms) from 61% of estimated incident cases in 2013-14 to 71% of estimated incident cases by 2017 while maintaining treatment success rate at 91%; To increase the number of TB patients who are screened for HIV infection from 3% in 2013-14 to 10% by 2017. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division xxxx xxxx Fund Portfolio Manager +41 58 791 1700 xxxx https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Pakistan Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases 5840360.00 Global Fund commitment to PAK-T-MCP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1412769.00 Global Fund disbursement to PAK-T-MCP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1058185.00 Global Fund disbursement to PAK-T-MCP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1194039.00 Global Fund disbursement to PAK-T-MCP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2175367.00 Global Fund disbursement to PAK-T-MCP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 7833228.00 Global Fund commitment to PAK-T-MCP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1738760.00 Global Fund disbursement to PAK-T-MCP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1209362.00 Global Fund disbursement to PAK-T-MCP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1913018.00 Global Fund disbursement to PAK-T-MCP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2972088.00 Global Fund disbursement to PAK-T-MCP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 892661.00 Global Fund commitment to PAK-T-MCP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 892661.00 Global Fund disbursement to PAK-T-MCP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>CM-other 1: Number of notified TB cases, all forms, contributed by non-NTP providers - private/non-governmental facilities</narrative> Module: TB care and prevention. <narrative>CM-other 1: Number of notified TB cases, all forms, contributed by non-NTP providers - private/non-governmental facilities</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 7843. Numerator: 8444. Numerator: 7843; Denominator: 85492; Percentage: 9.2%. Numerator: 8418. Numerator: 16392. Numerator: 13125. Numerator: 19613. Numerator: 14944. Numerator: 21350. Numerator: 16994. Numerator: 19513. <narrative>CM-other 2 Number of bacteriologically confirmed TB, New and relapse cases, contributed by non-NTP- private/non-governmental facilities</narrative> Module: TB care and prevention. <narrative>CM-other 2 Number of bacteriologically confirmed TB, New and relapse cases, contributed by non-NTP- private/non-governmental facilities</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 2704. Numerator: 4248. Numerator: 2704; Denominator: 36670; Percentage: 7.4%. Numerator: 4203. Numerator: 5238. Numerator: 6583. Numerator: 6402. Numerator: 7473. Numerator: 7272. Numerator: 8520. Numerator: 6327. <narrative>CM-other 3: Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period in non-NTP providers -private/non-governmental facilit</narrative> Module: TB care and prevention. <narrative>CM-other 3: Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period in non-NTP providers -private/non-governmental facilit</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 2534; Denominator: 2745. Numerator: 2034; Denominator: 2234. Numerator: 2534; Denominator: 2745. Numerator: 3669; Denominator: 4024. Numerator: 2919; Denominator: 3126. Numerator: 2461; Denominator: 2704. Numerator: 2502; Denominator: 2704. Numerator: 3825; Denominator: 4203. Numerator: 4822; Denominator: 5238. Numerator: 5991; Denominator: 6583. Numerator: 5914; Denominator: 6402. 47045-PAK-T-MC-3 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Contribute towards achieving the targets of National Strategic Plan aligned with End TB Strategy for reducing the burden of TB and MDR-TB in Pakistan - Pakistan (01-Jan-2018-30-Jun-2021)</narrative> Pakistan, Tuberculosis, Mercy Corps Goals: Contribute to achieving the goal of the national strategy to control TB in Pakistan which is to reduce by 50% the prevalence of TB by 2025 in comparison to 2011; Contribute towards decreasing the prevalence, by at least 5% per year from 2018 onwards, the prevalence of MDR-TB among TB patients who have never received any TB treament. Objectives: To increase TB case notification (all forms) from 70% of estimated incident cases in 2014-15 to 85% of estimated incident cases by 2020 while maintaining treatment success rate at 91%; To enhance MDR-TB enrollment from 18% of estimated cases in 2014-15 to 33% of estimated by 2020; To increase the number of TB patients who are screened for HIV infection from 3% in 2014-15 to 10% by 2020. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division xxxx xxxx Fund Portfolio Manager +41 58 791 1700 xxxx https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Pakistan Tuberculosis Multicomponent, RSSH Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage Multicomponent -> Payment for results -> Payment for results Multicomponent -> Program management -> Grant management RSSH -> RSSH: Health management information systems and M&E -> Analysis, evaluations, reviews and transparency RSSH -> RSSH: Health management information systems and M&E -> Routine reporting Tuberculosis -> TB care and prevention -> Case detection and diagnosis (TB care and prevention) Tuberculosis -> TB care and prevention -> Community TB care delivery Tuberculosis -> TB care and prevention -> Engaging all care providers (TB care and prevention) Tuberculosis -> TB care and prevention -> Key populations (TB care and prevention) - Others Tuberculosis -> TB care and prevention -> Treatment (TB care and prevention) 3694161.76 3688455.51 6383803.71 6077387.97 5280682.66 Global Fund commitment to PAK-T-MCP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 350821.66 Global Fund disbursement to PAK-T-MCP03 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 985145.00 Global Fund disbursement to PAK-T-MCP03 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 835133.00 Global Fund disbursement to PAK-T-MCP03 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 946873.00 Global Fund disbursement to PAK-T-MCP03 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1218876.00 Global Fund disbursement to PAK-T-MCP03 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 5835494.33 Global Fund commitment to PAK-T-MCP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -943834.00 Global Fund commitment to PAK-T-MCP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1922422.89 Global Fund disbursement to PAK-T-MCP03 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 161378.00 Global Fund disbursement to PAK-T-MCP03 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1721245.00 Global Fund disbursement to PAK-T-MCP03 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1549312.57 Global Fund disbursement to PAK-T-MCP03 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -481135.87 Global Fund commitment to PAK-T-MCP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2719272.54 Global Fund commitment to PAK-T-MCP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1172555.08 Global Fund disbursement to PAK-T-MCP03 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1546717.46 Global Fund disbursement to PAK-T-MCP03 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 3383374.00 Global Fund commitment to PAK-T-MCP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 3383374.00 Global Fund disbursement to PAK-T-MCP03 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 13290.00 Funds returned to the Global Fund from PAK-T-MCP03 (International NGO). Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria -13290.00 Global Fund commitment to PAK-T-MCP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 3694161.74 Expenditure reported by Mercy Corps for PAK-T-MCP03, Jan 2018 to Dec 2018. Mercy Corps 3687998.98 Expenditure reported by Mercy Corps for PAK-T-MCP03, Jan 2019 to Dec 2019. Mercy Corps 4985034.98 Expenditure reported by Mercy Corps for PAK-T-MCP03, Jan 2020 to Dec 2020. Mercy Corps 3360613.58 Expenditure reported by Mercy Corps for PAK-T-MCP03, Jan 2021 to Jun 2021. Mercy Corps -431405.05 Expenditure reported by Mercy Corps for PAK-T-MCP03, Jul 2021 to Dec 2021. Mercy Corps <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative> <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 2481; Denominator: 66714. Numerator: 4522; Denominator: 60062. Numerator: 1443; Denominator: 38916. <narrative>TCP Other- 4: Proportion of bacteriologically positive TB cases among new and relapse pulmonary TB cases.</narrative> <narrative>TCP Other- 4: Proportion of bacteriologically positive TB cases among new and relapse pulmonary TB cases.</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 12562; Denominator: 33405. Numerator: 11286; Denominator: 45046. Numerator: 12152; Denominator: 32113. <narrative>TCP Other-2: Number of samples tested on Xpert through specimen transportation</narrative> <narrative>TCP Other-2: Number of samples tested on Xpert through specimen transportation</narrative> Aggregation: Non cumulative. <narrative>TCP Other-3: Proportion of contacts of people with bacteriologically confirmed TB who were screened for active TB</narrative> <narrative>TCP Other-3: Proportion of contacts of people with bacteriologically confirmed TB who were screened for active TB</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 1397; Denominator: 27233. Numerator: 31036; Denominator: 56429. Numerator: 16090; Denominator: 24607. <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative> Module: TB care and prevention. <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Module: TB care and prevention. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 30894. Numerator: 314632. Numerator: 314632. Numerator: 314632. Numerator: 314632. Numerator: 314632. Numerator: 314632. Numerator: 314632. Numerator: 41758. Numerator: 41758. Numerator: 41758. Numerator: 41758. Numerator: 41758. Numerator: 41758. Numerator: 41758. Numerator: 137718. Numerator: 176440. Numerator: 176440. Numerator: 176440. Numerator: 176440. Numerator: 176440. Numerator: 176440. Numerator: 176440. Numerator: 179950. Numerator: 179950. Numerator: 179950. Numerator: 179950. Numerator: 179950. Numerator: 179950. Numerator: 179950. Numerator: 19308. Numerator: 18084. Numerator: 16348; Denominator: 18084; Percentage: 90.4%. Numerator: 1736; Denominator: 18084; Percentage: 9.6%. Numerator: 8821; Denominator: 18084; Percentage: 48.8%. Numerator: 9263; Denominator: 18084; Percentage: 51.2%. Numerator: 19308. Numerator: 18169. Numerator: 15746; Denominator: 18169; Percentage: 86.7%. Numerator: 2423; Denominator: 18169; Percentage: 13.3%. Numerator: 8744; Denominator: 18169; Percentage: 48.1%. Numerator: 9425; Denominator: 18169; Percentage: 51.9%. Numerator: 19308. Numerator: 19603. Numerator: 16988; Denominator: 19603; Percentage: 86.7%. Numerator: 2615; Denominator: 19603; Percentage: 13.3%. Numerator: 9336; Denominator: 19603; Percentage: 47.6%. Numerator: 10267; Denominator: 19603; Percentage: 52.4%. Numerator: 21098. Numerator: 18998. Numerator: 15968; Denominator: 18998; Percentage: 84.1%. Numerator: 3030; Denominator: 18998; Percentage: 15.9%. Numerator: 9158; Denominator: 18998; Percentage: 48.2%. Numerator: 9840; Denominator: 18998; Percentage: 51.8%. Numerator: 23473. Numerator: 18332. Numerator: 16065; Denominator: 18332; Percentage: 87.6%. Numerator: 2267; Denominator: 18332; Percentage: 12.4%. Numerator: 8701; Denominator: 18332; Percentage: 47.5%. Numerator: 9631; Denominator: 18332; Percentage: 52.5%. Numerator: 23476. Numerator: 21037. Numerator: 18323; Denominator: 21037; Percentage: 87.1%. Numerator: 2714; Denominator: 21037; Percentage: 12.9%. Numerator: 9885; Denominator: 21037; Percentage: 47%. Numerator: 11152; Denominator: 21037; Percentage: 53%. Numerator: 60062. Numerator: 38916. Numerator: 33668; Denominator: 38916; Percentage: 86.5%. Numerator: 5248; Denominator: 38916; Percentage: 13.5%. Numerator: 6346; Denominator: 20266; Percentage: 31.3%. Numerator: 18491; Denominator: 38916; Percentage: 47.5%. Numerator: 20425; Denominator: 38916; Percentage: 52.5%. <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Module: TB care and prevention. <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Geographic coverage: Subnational. Aggregation: Cumulative annually. Numerator: 187; Denominator: 228. Numerator: 255; Denominator: 300. Numerator: 289; Denominator: 299. Numerator: 261; Denominator: 300. Numerator: 215; Denominator: 237. Numerator: 300; Denominator: 333. Numerator: 245; Denominator: 257. Numerator: 338; Denominator: 375. Numerator: 296; Denominator: 309. <narrative>TCP other 1: Number of cases notified through chest camps</narrative> Module: TB care and prevention. <narrative>TCP other 1: Number of cases notified through chest camps</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Module: TB care and prevention. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 13544; Denominator: 14212. Numerator: 14755; Denominator: 15866. Numerator: 17094; Denominator: 18141. Numerator: 13550; Denominator: 14570. Numerator: 15809; Denominator: 16767. Numerator: 17956; Denominator: 19308. Numerator: 16947; Denominator: 18084. Numerator: 17956; Denominator: 19308. Numerator: 17057; Denominator: 18168. Numerator: 17956; Denominator: 19308. Numerator: 18444; Denominator: 19510. Numerator: 19619; Denominator: 21098. Numerator: 18006; Denominator: 18998. Numerator: 37174; Denominator: 39972. Numerator: 29291; Denominator: 31766. 47045-PAK-T-MC-4 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Contribute towards achieving the targets of National Strategic Plan aligned with End TB Strategy for reducing the burden of TB and MDR-TB in Pakistan. - Pakistan (01-Jul-2021-31-Dec-2023)</narrative> Pakistan, Tuberculosis, Mercy Corps Goals: To reduce TB mortality rate by 40% by 2023 compared to 2015; To reduce estimated TB incidence by at least 4% in 2023 compared to 2015. Objectives: To detect and notify at least 1,300,000 cases of new TB episode during the years 2021 to 2023; To maintain the annual treatment success rate at 90% and over during the years 2021 to 2023; To enroll in treatment with 2nd line TB medicines 21,000 cases of MDR/RR-TB cases during the years 2021 to 2023; To ensure the provision of preventive TB therapy to at least 650,000 eligible people during the years 2021 to 2023. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division xxxx xxxx Fund Portfolio Manager +41 58 791 1700 xxxx https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Pakistan Tuberculosis Multicomponent, RSSH Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage Multicomponent -> Payment for results -> Payment for results Multicomponent -> Program management -> Grant management RSSH -> RSSH: Health management information systems and M&E -> Analysis, evaluations, reviews and transparency RSSH -> RSSH: Health management information systems and M&E -> Routine reporting Tuberculosis -> TB care and prevention -> Case detection and diagnosis (TB care and prevention) Tuberculosis -> TB care and prevention -> Community TB care delivery Tuberculosis -> TB care and prevention -> Engaging all care providers (TB care and prevention) Tuberculosis -> TB care and prevention -> Treatment (TB care and prevention) Tuberculosis -> TB/HIV -> Engaging all care providers (TB/HIV) 8578888.26 8842268.48 15794543.27 13140259.88 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 4648214.16 Global Fund disbursement to PAK-T-MCP04 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 3917249.96 Global Fund disbursement to PAK-T-MCP04 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -4574795.76 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 15786993.18 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2336654.18 Global Fund disbursement to PAK-T-MCP04 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2808808.83 Global Fund disbursement to PAK-T-MCP04 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 5303324.00 Global Fund disbursement to PAK-T-MCP04 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -5338206.17 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 7843751.00 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 3709174.00 Global Fund disbursement to PAK-T-MCP04 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2297737.57 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 4134577.00 Global Fund disbursement to PAK-T-MCP04 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2040267.78 Global Fund disbursement to PAK-T-MCP04 (Pooled Procurement Mechanism). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 221553.00 Global Fund disbursement to PAK-T-MCP04 (Pooled Procurement Mechanism). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -35916.79 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 23448.68 Funds returned to the Global Fund from PAK-T-MCP04 (Pooled Procurement Mechanism). Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria -23448.68 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 215100.00 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -215100.00 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -215100.00 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 215100.00 Funds returned to the Global Fund from PAK-T-MCP04 (Pooled Procurement Mechanism). Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria 44847.00 Funds returned to the Global Fund from PAK-T-MCP04 (International NGO). Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria -44847.00 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -1764946.00 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1764946.00 Funds returned to the Global Fund from PAK-T-MCP04 (Other 3rd Party). Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria 3963010.00 Expenditure reported by Mercy Corps for PAK-T-MCP04, Jul 2021 to Dec 2021. Mercy Corps 8298920.78 Expenditure reported by Mercy Corps for PAK-T-MCP04, Jan 2022 to Dec 2022. Mercy Corps 16689950.40 Expenditure reported by Mercy Corps for PAK-T-MCP04, Jan 2023 to Dec 2023. Mercy Corps -943129.34 Expenditure reported by Mercy Corps for PAK-T-MCP04, Jan 2024 to Jun 2024. Mercy Corps <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>2020 - Funding Request - Window 3 - Tuberculosis - Pakistan - English</narrative> Funding Request of funding request FR743-PAK-T-01. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Module: MDR-TB. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative> Module: TB care and prevention. <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative> Module: TB care and prevention. <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Module: TB care and prevention. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Module: TB care and prevention. <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 215; Denominator: 237. Numerator: 658; Denominator: 715. Numerator: 559; Denominator: 574. Numerator: 704; Denominator: 757. Numerator: 643; Denominator: 664. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative> Module: TB care and prevention. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 2481; Denominator: 66714. Numerator: 8291; Denominator: 84266. Numerator: 4916; Denominator: 48398. Numerator: 9563; Denominator: 90994. Numerator: 8746; Denominator: 67657. Numerator: 19126; Denominator: 181988. Numerator: 19746; Denominator: 140896. Numerator: 9563; Denominator: 90994. Numerator: 11000; Denominator: 73239. Numerator: 19136; Denominator: 186310. Numerator: 30195; Denominator: 183046. Numerator: 9568; Denominator: 93155. Numerator: 13555; Denominator: 88882. Numerator: 9568; Denominator: 93155. Numerator: 16640; Denominator: 94164. <narrative>TCP Other -1: Number of samples tested on Xpert through specimen transportation</narrative> Module: TB care and prevention. <narrative>TCP Other -1: Number of samples tested on Xpert through specimen transportation</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. <narrative>TCP Other- 3: Proportion of bacteriologically positive TB cases among new and relapse pulmonary TB cases.</narrative> Module: TB care and prevention. <narrative>TCP Other- 3: Proportion of bacteriologically positive TB cases among new and relapse pulmonary TB cases.</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 12562; Denominator: 33405. Numerator: 24666; Denominator: 61691. Numerator: 14047; Denominator: 37073. Numerator: 33070; Denominator: 66486. Numerator: 19772; Denominator: 51025. Numerator: 66140; Denominator: 132972. Numerator: 39899; Denominator: 110416. Numerator: 33070; Denominator: 66486. Numerator: 20127; Denominator: 59391. Numerator: 40966; Denominator: 68305. Numerator: 26613; Denominator: 72684. Numerator: 81932; Denominator: 136610. Numerator: 54685; Denominator: 149436. Numerator: 40966; Denominator: 68305. Numerator: 28072; Denominator: 76752. <narrative>TCP Other-2: Proportion of contacts of people with bacteriologically confirmed TB who were screened for active TB</narrative> Module: TB care and prevention. <narrative>TCP Other-2: Proportion of contacts of people with bacteriologically confirmed TB who were screened for active TB</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 13970; Denominator: 27233. Numerator: 71739; Denominator: 130435. Numerator: 37481; Denominator: 55721. Numerator: 194052; Denominator: 323420. Numerator: 103835; Denominator: 163100. Numerator: 97026; Denominator: 161710. Numerator: 49028; Denominator: 80079. Numerator: 97026; Denominator: 161710. Numerator: 54807; Denominator: 83021. Numerator: 286764; Denominator: 409664. Numerator: 154252; Denominator: 235328. Numerator: 143382; Denominator: 204832. Numerator: 74702; Denominator: 113152. Numerator: 143382; Denominator: 204832. Numerator: 79550; Denominator: 122176. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Module: TB care and prevention. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 59283; Denominator: 65065. Numerator: 40338; Denominator: 43375. Numerator: 33968; Denominator: 36553. Numerator: 134225; Denominator: 144328. Numerator: 82376; Denominator: 87398. Numerator: 55858; Denominator: 60062. Numerator: 36702; Denominator: 39024. Numerator: 78367; Denominator: 84266. Numerator: 45674; Denominator: 48374. Numerator: 169248; Denominator: 181988. Numerator: 132293; Denominator: 140051. Numerator: 84624; Denominator: 90994. Numerator: 63193; Denominator: 67203. Numerator: 84624; Denominator: 90994. Numerator: 69100; Denominator: 72848. 47045-PAK-T-MC-5 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Contribution toward achieving the targets of National Strategic Plan for Tuberculosis prevention, care and control in Pakistan - Pakistan (01-Jan-2024-31-Dec-2026)</narrative> Pakistan, Tuberculosis, Mercy Corps Goal: To reduce TB mortality rate by 35% in 2026 compared to 2015. Objectives: To increase the number of notified new TB episodes to at least 486,160 by 2026 and to maintain TB treatment success rate at more than 90% from 2024 onwards; To increase the number of detected and treated of MDR/RR-TB cases from 3,373 in 2021 to at least 7,700 by 2026 and their treatment success rate to at least 80% from 2024 onwards; To increase the proportion of notified TB cases with known HIV status from 52% in 2021 to 100 % by 2026 and to treat 100% of identified TB/HIV with ART every year; To improve and enhance TB prevention through i) tuberculosis preventive therapy of, at least, 80% of household contacts and PLHIV with no active TB in 2024 to 2026 and ii) strengthening infection control. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division xxxx xxxx Fund Portfolio Manager +41 58 791 1700 xxxx https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Pakistan Tuberculosis Multicomponent Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage Multicomponent -> Program management -> Grant management Tuberculosis -> Collaboration with other providers and sectors -> Private provider engagement in TB/DR-TB care Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB diagnosis/drug susceptibility testing (DST) Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB treatment, care and support Tuberculosis -> TB diagnosis, treatment and care -> TB screening and diagnosis Tuberculosis -> TB/DR-TB Prevention -> Preventive treatment Tuberculosis -> TB/HIV -> TB/HIV - Collaborative interventions 10178954.99 12316490.10 12169432.95 21244330.91 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2907387.49 Global Fund disbursement to PAK-T-MCP05 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 3953783.00 Global Fund disbursement to PAK-T-MCP05 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 215100.00 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 5336231.08 Global Fund disbursement to PAK-T-MCP05 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 215100.00 Global Fund disbursement to PAK-T-MCP05 (Pooled Procurement Mechanism). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 36050.00 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2697441.48 Global Fund disbursement to PAK-T-MCP05 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -6349487.86 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 4841476.01 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1897108.00 Global Fund disbursement to PAK-T-MCP05 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2882320.00 Global Fund disbursement to PAK-T-MCP05 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 36050.00 Global Fund disbursement to PAK-T-MCP05 (Pooled Procurement Mechanism). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1764946.00 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1764946.00 Global Fund disbursement to PAK-T-MCP05 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 5968634.00 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -62048.01 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 3025709.00 Global Fund disbursement to PAK-T-MCP05 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -2942925.00 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 7956024.58 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 152190.03 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2040904.58 Global Fund disbursement to PAK-T-MCP05 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 12846.00 Global Fund disbursement to PAK-T-MCP05 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 12846.00 Global Fund disbursement to PAK-T-MCP05 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 5901.00 Funds returned to the Global Fund from PAK-T-MCP05 (International NGO). Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria -5901.00 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 3077422.00 Global Fund disbursement to PAK-T-MCP05 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 932.00 Funds returned to the Global Fund from PAK-T-MCP05 (International NGO). Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria -932.00 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1303.46 Funds returned to the Global Fund from PAK-T-MCP05 (Pooled Procurement Mechanism). Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria -1303.46 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2812006.00 Global Fund disbursement to PAK-T-MCP05 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 10124512.99 Expenditure reported by Mercy Corps for PAK-T-MCP05, Jan 2024 to Dec 2024. Mercy Corps 11076457.00 Expenditure reported by Mercy Corps for PAK-T-MCP05, Jan 2025 to Dec 2025. Mercy Corps <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>2023 - Funding Request - Window 1 - Tuberculosis - Pakistan - English</narrative> Funding Request of funding request FR1402-PAK-T. <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 940. Numerator: 914; Denominator: 940; Percentage: 97.23%. Numerator: 26; Denominator: 940; Percentage: 2.77%. Numerator: 439; Denominator: 799; Percentage: 54.94%. Numerator: 501; Denominator: 940; Percentage: 53.3%. Numerator: 915. Numerator: 1926. Numerator: 1481. Numerator: 1011. Numerator: 832. Numerator: 2596. Numerator: 1802. Numerator: 1263. Numerator: 1333. Numerator: 892. Numerator: 865. Numerator: 27. Numerator: 421. Numerator: 471. Numerator: 1395. Numerator: 1413. <narrative>Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes</narrative> Module: RSSH/PP: Laboratory systems (including national and peripheral). <narrative>Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other. Numerator: 664; Denominator: 686. Numerator: 808; Denominator: 851. Numerator: 808; Denominator: 851. Numerator: 808; Denominator: 851. <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 140896. Numerator: 116535; Denominator: 140896; Percentage: 82.71%. Numerator: 24361; Denominator: 140896; Percentage: 17.29%. Numerator: 39898; Denominator: 140896; Percentage: 28.32%. Numerator: 65589; Denominator: 140896; Percentage: 46.55%. Numerator: 75306; Denominator: 140896; Percentage: 53.45%. Numerator: 157286. Numerator: 204181. Numerator: 74819. Numerator: 82467. Numerator: 105406. Numerator: 208992. Numerator: 206354. Numerator: 101997. Numerator: 106995. Numerator: 100877. Numerator: 85615. Numerator: 15262. Numerator: 36679. Numerator: 47844. Numerator: 53033. Numerator: 110970. Numerator: 112868. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative> Module: TB diagnosis, treatment and care. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 57236; Denominator: 140896. Numerator: 70778.8; Denominator: 157286. Numerator: 97301; Denominator: 204181. Numerator: 33668.55; Denominator: 74819. Numerator: 37110.15; Denominator: 82467. Numerator: 42221; Denominator: 105406. Numerator: 114945.7; Denominator: 208992. Numerator: 110274; Denominator: 206354. Numerator: 56098.35; Denominator: 101997. Numerator: 58847.25; Denominator: 106995. Numerator: 54596; Denominator: 100877. Numerator: 72130.5; Denominator: 110970. Numerator: 73364.2; Denominator: 112868. <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 10624; Denominator: 140896. Numerator: 18453.4; Denominator: 157286. Numerator: 11112; Denominator: 204181. Numerator: 8239.74; Denominator: 74819. Numerator: 10213.74; Denominator: 82467. Numerator: 6375; Denominator: 105406. Numerator: 20511.4; Denominator: 208992. Numerator: 13408; Denominator: 206354. Numerator: 10255.74; Denominator: 101997. Numerator: 10255.74; Denominator: 106995. Numerator: 7737; Denominator: 100877. Numerator: 10255.74; Denominator: 110970. Numerator: 10255.74; Denominator: 112868. <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 130870; Denominator: 140896. Numerator: 138833; Denominator: 157286. Numerator: 193179; Denominator: 204181. Numerator: 66579.7; Denominator: 74819. Numerator: 72253.3; Denominator: 82467. Numerator: 99090; Denominator: 105406. Numerator: 188480.6; Denominator: 208992. Numerator: 193138; Denominator: 206354. Numerator: 91741.3; Denominator: 101997. Numerator: 96739.3; Denominator: 106995. Numerator: 93337; Denominator: 100877. Numerator: 100714.3; Denominator: 110970. Numerator: 102612.3; Denominator: 112868. <narrative>TBDT-Other 1: Percentage of samples tested using GeneXpert out of the total number of samples transported through specimen transportation</narrative> Module: TB diagnosis, treatment and care. <narrative>TBDT-Other 1: Percentage of samples tested using GeneXpert out of the total number of samples transported through specimen transportation</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 40143; Denominator: 60274. Numerator: 55064; Denominator: 84714. Numerator: 238774; Denominator: 314408. Numerator: 21341; Denominator: 32833. Numerator: 33723; Denominator: 51881. Numerator: 111305; Denominator: 140421. Numerator: 141834; Denominator: 202619. Numerator: 330280; Denominator: 352575. Numerator: 61848; Denominator: 88354. Numerator: 79986; Denominator: 114265. Numerator: 179614; Denominator: 186964. Numerator: 107138; Denominator: 142850. Numerator: 127220; Denominator: 169626. <narrative>TBDT-Other 2: Proportion of bacteriologically positive TB cases among new and relapse pulmonary TB cases.</narrative> Module: TB diagnosis, treatment and care. <narrative>TBDT-Other 2: Proportion of bacteriologically positive TB cases among new and relapse pulmonary TB cases.</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 39899; Denominator: 110416. Numerator: 59000; Denominator: 117964.8. Numerator: 62989; Denominator: 164418. Numerator: 28061; Denominator: 56114.3. Numerator: 30939; Denominator: 61850.5. Numerator: 32190; Denominator: 82870. Numerator: 45909; Denominator: 76497.9. Numerator: 94059; Denominator: 156744.4. Numerator: 75195; Denominator: 161178. Numerator: 48150; Denominator: 80246.5. Numerator: 36679; Denominator: 78303. Numerator: 54096; Denominator: 83227.7. Numerator: 55016; Denominator: 84651.2. <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 82242; Denominator: 87398. Numerator: 134146.1; Denominator: 149051.2. Numerator: 172760; Denominator: 183046. Numerator: 67072.32; Denominator: 74524.8. Numerator: 67073.76; Denominator: 74526.4. Numerator: 88739; Denominator: 94164. Numerator: 67337.1; Denominator: 74819. Numerator: 141557.4; Denominator: 157286. Numerator: 187202; Denominator: 204178. Numerator: 74220.3; Denominator: 82467. Numerator: 95014; Denominator: 105404. Numerator: 91797.3; Denominator: 101997. Numerator: 96295.5; Denominator: 106995. <narrative>Contact investigation coverage: Proportion of contacts of people with bacteriologically confirmed TB evaluated for TB among those eligible</narrative> Module: TB/DR-TB Prevention. <narrative>Contact investigation coverage: Proportion of contacts of people with bacteriologically confirmed TB evaluated for TB among those eligible</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 103835; Denominator: 163100. Numerator: 77196; Denominator: 140305. Numerator: 162305; Denominator: 295000. Numerator: 164866; Denominator: 268343. Numerator: 85109; Denominator: 154695. Numerator: 78566; Denominator: 132261. Numerator: 305752; Denominator: 470295. Numerator: 188338; Denominator: 308528. Numerator: 149236; Denominator: 229545. Numerator: 156516; Denominator: 240750. Numerator: 93171; Denominator: 151011. Numerator: 202889; Denominator: 270480. Numerator: 206328; Denominator: 275080. <narrative>Number of people in contact with TB patients who began preventive therapy</narrative> Module: TB/DR-TB Prevention. <narrative>Number of people in contact with TB patients who began preventive therapy</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.